EP Patent

EP2853273A1 — Bone repair promoter

Assigned to Daiichi Sankyo Co Ltd · Expires 2015-04-01 · 11y expired

What this patent protects

The present invention provides a bone repair promoter containing as an active ingredient at least one kind of B-type natriuretic peptide receptor agonist.

USPTO Abstract

The present invention provides a bone repair promoter containing as an active ingredient at least one kind of B-type natriuretic peptide receptor agonist.

Drugs covered by this patent

Patent Metadata

Patent number: EP2853273A1
Jurisdiction: EP
Classification: —
Expires: 2015-04-01
Drug substance claim: No
Drug product claim: No
Assignee: Daiichi Sankyo Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.